Avoiding Scale-Up Surprises: Applying AI and Rapid Prototyping to Media and Process Development
March 26, 2026 | 1:00 PM ET
As biologics grow more complex and development timelines tighten, early decisions around media and process design can significantly impact scalability. Traditional workflows may not reveal manufacturability challenges until programs near scale-up—when changes are costly and disruptive.
In this webinar, experts from Thermo Fisher Scientific explore how integrating AI, data modeling, and rapid prototyping earlier in development can help reduce risk and improve downstream success. The session follows a representative development journey, beginning with computational insights and analytical testing, progressing through media and process optimization, and advancing to rapid prototyping and preparation for large-scale cGMP manufacturing.
Attendees will learn how to evaluate manufacturability earlier, use predictive modeling to inform development choices, and apply rapid prototyping to assess media and process performance before technology transfer. The discussion will focus on practical strategies to identify potential bottlenecks, align early development decisions with manufacturing realities, and strengthen confidence ahead of cGMP scale-up.
Speakers include Femi Egbebi, Senior Product Manager, BioProduction Group; Robert Brach, Product Manager, BioProduction Group; and Weizhong Li, PhD, Principal Scientist, Computational Data, BioProduction Group, Thermo Fisher Scientific.
This session is designed for process development, upstream, and CMC professionals seeking a more data-driven, scalable approach to biologics development.
